Mpox Cases in Serbia, 2022
In Serbia, mpox mainly affected MSM aged 30-39 and living in urban areas. Health promotion and vaccine implementation should be prioritized in populations with a higher risk.
Authors
- Aleksandar Medarević (ORCID: https://orcid.org/0000-0002-7483-3625)
- Verica Jovanović (ORCID: https://orcid.org/0000-0002-9650-0709)
- Dragana Plavša (ORCID: https://orcid.org/0000-0002-8294-9118)
- Mitra B. Drakulović
- Jelena Protić (ORCID: https://orcid.org/0000-0002-8024-1204)
- Petar Đurić (ORCID: https://orcid.org/0000-0002-0881-5170)
- Jovan Malinić
- Nana Mebonia
Institutions
- Institute of Virology, Vaccines and Sera “Torlak” (RS)
- Institute of Public Health of Serbia (RS)
- European Centre for Disease Prevention and Control (SE)
Publication Details
- Journal
- Infectious Disease Reports
- Published
- 2025-01-27
- DOI
- https://doi.org/10.3390/idr17010009
- Citations
- 1
- Primary Topic
- Poxvirus research and outbreaks
- Type
- article
- Field-Weighted Citation Impact
- 1.04